HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hani Shennib Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, A. G. L. Articles by Shennib, H. Search for Related Content PubMed PubMed Citation Articles by Lee, A. G. L. Articles by Shennib, H.

J Thorac Cardiovasc Surg 1998;115:822-827
© 1998 Mosby, Inc.

CARDIAC AND PULMONARY REPLACEMENT

A novel charcoal-induced model of obliterative bronchiolitis–like lesions: Implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis

This work was funded in part by the Canadian Cystic Fibrosis Foundation, the Quebec Heart and Stroke Foundation, and the Quebec Lung Association. Allan G. L. Lee is a recipient of the Canadian Cystic Fibrosis Foundation. Hani Shennib is a senior scholar of the Fonds du Récherche en Santé Québec.

Received for publication Feb. 7, 1997. Revisions requested May 21, 1997; revisions received Sept. 17, 1997. Accepted for publication Sept. 17, 1997. Address for reprints: Hani Shennib, MD, The Montreal General Hospital 1650 Cedar Ave., Suite L9-120, Montreal, Quebec H3G 1A4, Canada.

Abstract

Objectives: In this study, we describe the development of a nonallogeneic animal model of obliterative bronchiolitis–like lesions. Furthermore, we examined whether chronic rejection alone can lead to the development of obliterative bronchiolitis or whether additional nonspecific airway inflammation is required.
Methods: Part I: Rats were intratracheally injected with 0.2 ml of activated charcoal or sorbitol solution (carrier for charcoal control). Animals were put to death beginning at 2 weeks up to 20 weeks. Part II: Animals were divided into three groups: group I, underimmunosuppressed Brown Norway to Lewis lung allografts; group II, charcoal-treated underimmunosuppressed allografts; and group III, charcoal-treated rats. Animals were put to death at 3 months after transplantation.
Results: Part I: In charcoal-laden bronchioles, subacute nonspecific airway inflammation was detected at 2 weeks. Slow, subclinical fibroproliferation ensued during the following weeks. Obliterative bronchiolitis–like lesions were observed in 80% of charcoal-treated animals at 12 weeks. Part II: Allografts developed extensive vascular lesions consistent with acute and chronic vascular rejection. Obliterative bronchiolitis–like lesions were scarcely detected. Charcoal-treated allografts demonstrated evidence of diffuse and severe obliterative bronchiolitis–like lesions.
Conclusions: Transtracheal injection of activated charcoal into native lungs results in slowly progressive airway injury and inflammation leading to obliterative airway lesions. Inadequate immunosuppression primarily results in chronic vascular rejection but not obliterative bronchiolitis. Underimmunosuppressed allografts subjected to nonspecific airway inflammation develop obliterative airway lesions that are more prominent than in native lungs. This suggests that a cofactor to chronic rejection is likely necessary for the development of lung transplant obliterative bronchiolitis.

This article has been cited by other articles:

				T. Murakawa, M. M. Kerklo, M. R. Zamora, Y. Wei, R. G. Gill, P. M. Henson, F. L. Grover, and M. R. Nicolls Simultaneous LFA-1 and CD40 Ligand Antagonism Prevents Airway Remodeling in Orthotopic Airway Transplantation: Implications for the Role of Respiratory Epithelium as a Modulator of Fibrosis J. Immunol., April 1, 2005; 174(7): 3869 - 3879. [Abstract] [Full Text] [PDF]

				G. R. Graff, J. Stark, J. W. Berkenbosch, G. W. Holcomb III, and R. E. Garola Chronic Lung Disease After Activated Charcoal Aspiration Pediatrics, May 1, 2002; 109(5): 959 - 961. [Abstract] [Full Text] [PDF]

				M. Shannon Ingestion of Toxic Substances by Children N. Engl. J. Med., January 20, 2000; 342(3): 186 - 191. [Full Text] [PDF]

				F. M. Wagner, A. Weber, J.-W. Park, S. Schiemanck, S. M. Tugtekin, V. Gulielmos, and S. Schuler New telemetric system for daily pulmonary function surveillance of lung transplant recipients Ann. Thorac. Surg., December 1, 1999; 68(6): 2033 - 2038. [Abstract] [Full Text] [PDF]